COMMUNIQUÉS West-GlobeNewswire

Profusa Secures Lumee™ Oxygen Platform Distributor in Spain
31/07/2025
BERKELEY, Calif, July 31, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the [...]
Vericel Reports Second Quarter 2025 Financial Results
31/07/2025
Total Revenue Growth of 20% to $63.2 Million, with MACI Revenue Growth of 21% to $53.5 Million Gross Margin Increased More than 400 Basis Points to 74% Adjusted EBITDA Growth of 112% to $13.4 Million, with Adjusted [...]
MaxCyte Announces Strategic Platform Licensing Agreement with Anocca AB to Advance TCR-T Cell Therapy Pipeline
31/07/2025
MaxCyte’s Flow Electroporation® Technology will support non-viral gene editing in the manufacture of Anocca’s TCR-T cell therapies ROCKVILLE, Md., July 31, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc ., (Nasdaq: MXCT), a [...]
Akebia Therapeutics to Report Second Quarter 2025 Financial Results and Discuss Recent Business Highlights
31/07/2025
Akebia to Host Conference Call on August 7, 2025, at 8:00 a.m. EDT CAMBRIDGE, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA) today announced plans to release its financial results [...]
LifeMD Names COO and Promotes Two Executives
31/07/2025
NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual healthcare services, today announced the appointment of Shayna Webb Dray as its Chief Operating Officer. Ms. Webb [...]
Lexicon Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
31/07/2025
THE WOODLANDS, Texas, July 31, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Nasdaq’s listing qualifications staff has determined that the closing bid price of the Company’s [...]
Bavarian Nordic Announces Closing of Sale of Priority Review Voucher and Upgrades its 2025 Financial Guidance
31/07/2025
COPENHAGEN, Denmark, July 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced the completion of the sale of its Priority Review Voucher (PRV). Upon completion, the company received a cash consideration of USD 160 [...]
Accelerating Alzheimer’s Research: Groundbreaking Alzheimer's Disease Dataset Now Available to the Public
31/07/2025
Data from Most Deeply Characterized Cohort Across Alzheimer's Disease Released by Global Alzheimer’s Platform Foundation and Alzheimer’s Disease Data Initiative WASHINGTON, July 31, 2025 (GLOBE NEWSWIRE) -- The Global [...]
Silexion Therapeutics Announces New Preclinical Data Showing Up to 97% Inhibition of Cancer Cell Growth, Including New Evidence Against New Previously Untested KRAS Mutation
31/07/2025
New Results Reveal Unprecedented Inhibition Rates and First Evidence of SIL204's Efficacy Against Previously Untested KRAS Q61H Mutation in Human Cancer Cells, Significantly Expanding its Pan-KRAS Potential; Company on [...]
ADR Ratio Change Effective
31/07/2025
July 31, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) ADR Ratio Change Effective ADSs Outstanding Post Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company [...]
CoRegen, Inc. Appoints Biotech Veteran Sonal Gupta, M.D., Ph.D., as Chief Medical Officer
31/07/2025
HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- CoRegen , a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of cancer, today announced the appointment of [...]
Elucent Medical Marks 25,000 Lives Impacted Through EnVisio® Technology
31/07/2025
MINNEAPOLIS, July 31, 2025 (GLOBE NEWSWIRE) -- Elucent Medical is proud to announce that more than 25,000 successful procedures have been performed using the EnVisio® In-Body Spatial Intelligence™ platform. This [...]
AIM ImmunoTech Announces Closing of $8.0 Million Public Offering
31/07/2025
OCALA, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (the “Company”), today announced the closing of its previously announced public offering of an aggregate of 2,000,000 shares of its [...]
The Global Biologics Outsourcing Market Accounted for $20.7B in 2024 Driven by Rising Demand for Modality-Specific, End-to-End CDMO Capabilities, Finds Alira Health
31/07/2025
Annual, signature publication provides updated analysis of global CDMO trends, market shifts, and the accelerating impact of advanced therapies FRAMINGHAM, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Alira Health, a global [...]
GRI Bio Reports 6-Week Interim Biomarker Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
31/07/2025
Biomarkers at 6-week interim analysis show a positive impact on fibrogenesis, fibrolysis and potentially the initiation of a repair response The Independent Data Monitoring Committee (IDMC) has recommended to continue [...]
UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock
31/07/2025
JUPITER, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision [...]
Little Leaves Behavioral Services Opens Two New Locations in Maryland
31/07/2025
ABA therapy centers in Middle River and Owings Mills expand access to high-quality, early intervention services for young children with autism SILVER SPRING, Md., July 31, 2025 (GLOBE NEWSWIRE) -- Little Leaves [...]
Palisade Bio Receives Notice of Allowance for Composition of Matter Patent Covering Lead Product Candidate PALI-2108 in China
31/07/2025
PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn’s disease (FSCD) and ulcerative colitis (UC), to address significant unmet medical needs Inflammatory [...]
Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics
31/07/2025
Acquisition strengthens Supernus’ leading presence in neuropsychiatric conditions with an innovative commercial product, ZURZUVAE® (zuranolone), and a novel CNS discovery platform, accelerating mid- to long-term revenue [...]

Pages